²¹³Bi-anti-EGFR radioimmunoconjugates and X-ray irradiation trigger different cell death pathways in squamous cell carcinoma cells

Nucl Med Biol. 2014 Jan;41(1):68-76. doi: 10.1016/j.nucmedbio.2013.09.010. Epub 2013 Oct 9.

Abstract

Introduction: Treatment of patients with squamous cell carcinoma of head and neck is hampered by resistance of tumor cells to irradiation. Additional therapies enhancing the effect of X-ray irradiation may be beneficial. Antibodies targeting EGFR have been shown to improve the efficacy of radiation therapy. Therefore, we analyzed cytotoxicity of (213)Bi-anti-EGFR immunoconjugates in combination with X-ray irradiation.

Methods: The monoclonal anti-EGFR antibody matuzumab was coupled to CHX-A"-DTPA forming stable complexes with (213)Bi. Cytotoxicity of X-ray radiation, of treatment with (213)Bi-anti-EGFR monoclonal antibodies (MAb) or of a combined treatment regimen was assayed using cell proliferation and colony formation assays in UD-SCC5 cells. Key proteins of cell-cycle arrest and cell death were examined by Western blot analysis. Cell cycle analysis was performed by flow cytometry. DNA double-strand breaks were detected via γH2AX and quantified using Definiens™ software.

Results: Irradiation with X-rays or treatment with (213)Bi-anti-EGFR-MAb resulted in median lethal dose (LD50) values of 12 Gy or 130 kBq/mL, respectively. Treatment with 37 kBq/mL of (213)Bi-anti-EGFR-MAb or 2 Gy of X-rays had only little effect on colony formation of UD-SCC5 cells. In contrast, a combined treatment regimen (37 kBq/mL plus 2 Gy) significantly decreased colony formation and enhanced the formation of DNA double-strand breaks. As revealed by flow cytometry, radiation treatments caused accumulation of cells in the G0/G1 phase. Both treatment with (213)Bi-anti-EGFR immunoconjugates and application of the combined treatment regimen triggered activation of genes of signaling pathways involved in cell-cycle arrest and induction of apoptosis like p21/Waf, GADD45, Puma and Bax, which were only marginally modulated by X-ray irradiation of cells.

Conclusions: (213)Bi-anti-EGFR-MAb enhances cytotoxicity of X-ray irradiation in UD-SCC5 cells most probably due to effective induction of DNA double-strand breaks. Induction of genes involved in cell-cycle arrest and cell death is almost exclusively due to (213)Bi-anti-EGFR-MAb and seems to be independent of p53 function.

Keywords: Apoptosis; Cell-cycle arrest; Cytotoxicity; Head and neck squamous cell carcinoma; Radioimmunotherapy; UD-SCC5 cells; α-emitter (213)Bi.

MeSH terms

  • Alpha Particles / therapeutic use
  • Antibodies, Monoclonal / immunology
  • Antibody Specificity
  • Apoptosis / radiation effects*
  • Bismuth / therapeutic use*
  • Carcinoma, Squamous Cell / pathology*
  • Carcinoma, Squamous Cell / radiotherapy
  • Cell Line, Tumor
  • ErbB Receptors / immunology*
  • G1 Phase Cell Cycle Checkpoints / radiation effects
  • Head and Neck Neoplasms / pathology
  • Head and Neck Neoplasms / radiotherapy
  • Humans
  • Immunoconjugates / therapeutic use*
  • Linear Energy Transfer
  • Radioimmunotherapy
  • Radioisotopes / therapeutic use*
  • Signal Transduction / radiation effects
  • Survival Analysis
  • X-Ray Therapy*

Substances

  • Antibodies, Monoclonal
  • Immunoconjugates
  • Radioisotopes
  • EGFR protein, human
  • ErbB Receptors
  • Bismuth